Before revision:  These modules are trained together on drug combination screen as well as abundant drug-target interaction data. Our model is trained and evaluated on two SARS-CoV-2 drug combination screens and achieves 0.777 test AUC , which is 10\% higher than the model trained without drug-target interaction  .
After revision:  This design enables the model to .